Given Tight U.S. Economy, Science Leaders Consider FY 1995 R&D Budget Satisfactory

They say the proposal may be the best they can get, but Rep. George Brown warns that it may not get through Congress intact Officials at major scientific societies and associations say they are generally satisfied with the Clinton administration's $71 billion budget request for science research and development in the 1995 fiscal year. The proposed funding levels, they contend, are about as favorable for the research community as cou

Written byBarton Reppert
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

But Rep. George E. Brown, Jr. (D-Calif.), chairman of the House Science, Space, and Technology Committee--and regarded widely as Congress' No. 1 science expert--has expressed serious concern over the proposals and how they are likely to fare at the hands of his colleagues on Capitol Hill.

The budget, released early last month, includes a 6 percent increase for the National Science Foundation, up to a level of $3.2 billion next year, and a 4.7 percent increase for the National Institutes of Health, up to $10.994 billion in fiscal 1995, beginning on October 1.

Albert H. Teich, director of science and policy programs at the American Association for the Advancement of Science, observes that "the budget is consistent with what the administration has stated its priorities are. They're essentially putting their money where their mouth is."

Teich adds that, "considering the overall state of federal finances and the caps on discretionary ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies